Daily intake of low-dose aspirin did not lower the risk of dying from cancer or heart disease but did reduce first heart attacks and strokes by 10%, according to an analysis of nine trials involving more than 102,000 participants. U.K. researchers also found that daily low-dose aspirin therapy put patients at risk for serious bleeding events. Experts not involved in the study cautioned patients to talk with a provider before stopping aspirin therapy.

Full Story:
HealthDay News

Related Summaries